The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: India-based Orchid Pharma entered into a strategic partnership with Europe-based Allecra Therapeutics to deve...
Singapore: Munich-based Wacker Group is restructuring its sales network for biotech products in Asia to enhance efficien...
Thanks to the Human Genome Project, scientists now have a set of tools that can be readily used to understand the comple...
Singapore: In a bid to expand its product portfolio, India's fourth largest domestic drug maker (in terms of revenue) is...
Singapore: ClinACE has collaborated with a stem cell banking and therapy company for conducting end-to-end clinical deve...
Bangalore: India-based premier biotechnology company, Biocon, has been ranked 19th in Science magazine's annual global '...
Bangalore: Improving access through innovation and research and development aimed at finding tomorrow's cures will conti...
Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Pra...
New Delhi: A month after the Indian government banned the popular anti-diabetes drug Pioglitazone, it is now planning to...
Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been...
Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...
New Delhi: The global business intelligence firm, ResearchandMarket has filed their latest report with their projections...
Singapore: India's leading drug firm Strides Arcolab, with an agenda to foray into the semi-solid market in the US, has ...
A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...
Bangalore: Ranbaxy is going to exit its Bangalore-based vaccine manufacturing company, Biovel, according to Business Sta...
Bangalore: LifeCell International, India's largest and most accredited stem cell bank, secured an investment of $7 milli...
Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...
